M&ARoche acquires Telavant Holdings to win TLA1 raceLatest NewsAnalysts describe as sporting the €7.1bn for Roche AG’s acquisition of Roivant subsidiary Telavant Holdings. Read more 24 October 2023 https://european-biotechnology.com/wp-content/uploads/2024/04/tl1a-diagram_Prometheus.png 362 1140 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2023-10-24 11:37:222024-07-09 13:17:22Roche acquires Telavant Holdings to win TLA1 race